Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick K Ha

Showing results (31-40 of 143) with videos related to

Pageof 15
Sort By:
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|November 9, 2005
Short hospital stay after neck dissectionPatrick K Ha, Marion E Couch, Ralph P Tufano, et al.
Head & Neck|October 19, 2011
Molecular biology of adenoid cystic carcinomaJia Liu, Chunbo Shao, Marietta L Tan, et al.
Head and Neck Pathology|April 8, 2014
Mucoepidermoid carcinoma does not harbor transcriptionally active high risk human papillomavirus even in the absence of the MAML2 translocationJustin A Bishop, Raluca Yonescu, Denise Batista, et al.
The American Journal of Surgical Pathology|November 9, 2020
MYB RNA In Situ Hybridization Facilitates Sensitive and Specific Diagnosis of Adenoid Cystic Carcinoma Regardless of Translocation StatusLisa M Rooper, Kara A Lombardo, Bahram R Oliai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2016
Whole-Exome Sequencing of Salivary Gland Mucoepidermoid CarcinomaHyunseok Kang, Marietta Tan, Justin A Bishop, et al.
Cancers|August 26, 2023
Human Papillomavirus-Associated Oropharyngeal Cancer: Global Epidemiology and Public Policy ImplicationsSifon Ndon, Amritpal Singh, Patrick K Ha, et al.
Molecular Cancer Therapeutics|May 5, 2026
Potent anti-tumor activity of the AXL-targeted antibody-drug conjugate, mipasetamab uzoptirine (ADCT-601), in preclinical models of adenoid cystic carcinomaJoseph O Humtsoe, Leilani Jones, Anita Pothukuchi, et al.
Cancers|February 15, 2022
NSAIDs Overcome <i>PIK3CA</i> Mutation-Mediated Resistance to EGFR Inhibition in Head and Neck Cancer Preclinical ModelsHua Li, Noah D Peyser, Yan Zeng, et al.
Molecular Cancer Therapeutics|May 25, 2026
Potent Anti-Tumor Activity of the AXL-Targeted Antibody-Drug Conjugate, Mipasetamab Uzoptirine (ADCT-601), in Preclinical Models of Adenoid Cystic CarcinomaJoseph O Humtsoe, Leilani Jones, Anita Pothukuchi, et al.
International Journal of Cancer|November 26, 2002
Progression of microsatellite instability from premalignant lesions to tumors of the head and neckPatrick K Ha, Thomas A Pilkington, William H Westra, et al.
Pageof 15

Showing results (31-40 of 143) with videos related to

Sort By:
Pageof 15
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|November 9, 2005
Short hospital stay after neck dissectionPatrick K Ha, Marion E Couch, Ralph P Tufano, et al.
Head & Neck|October 19, 2011
Molecular biology of adenoid cystic carcinomaJia Liu, Chunbo Shao, Marietta L Tan, et al.
Head and Neck Pathology|April 8, 2014
Mucoepidermoid carcinoma does not harbor transcriptionally active high risk human papillomavirus even in the absence of the MAML2 translocationJustin A Bishop, Raluca Yonescu, Denise Batista, et al.
The American Journal of Surgical Pathology|November 9, 2020
MYB RNA In Situ Hybridization Facilitates Sensitive and Specific Diagnosis of Adenoid Cystic Carcinoma Regardless of Translocation StatusLisa M Rooper, Kara A Lombardo, Bahram R Oliai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2016
Whole-Exome Sequencing of Salivary Gland Mucoepidermoid CarcinomaHyunseok Kang, Marietta Tan, Justin A Bishop, et al.
Cancers|August 26, 2023
Human Papillomavirus-Associated Oropharyngeal Cancer: Global Epidemiology and Public Policy ImplicationsSifon Ndon, Amritpal Singh, Patrick K Ha, et al.
Molecular Cancer Therapeutics|May 5, 2026
Potent anti-tumor activity of the AXL-targeted antibody-drug conjugate, mipasetamab uzoptirine (ADCT-601), in preclinical models of adenoid cystic carcinomaJoseph O Humtsoe, Leilani Jones, Anita Pothukuchi, et al.
Cancers|February 15, 2022
NSAIDs Overcome <i>PIK3CA</i> Mutation-Mediated Resistance to EGFR Inhibition in Head and Neck Cancer Preclinical ModelsHua Li, Noah D Peyser, Yan Zeng, et al.
Molecular Cancer Therapeutics|May 25, 2026
Potent Anti-Tumor Activity of the AXL-Targeted Antibody-Drug Conjugate, Mipasetamab Uzoptirine (ADCT-601), in Preclinical Models of Adenoid Cystic CarcinomaJoseph O Humtsoe, Leilani Jones, Anita Pothukuchi, et al.
International Journal of Cancer|November 26, 2002
Progression of microsatellite instability from premalignant lesions to tumors of the head and neckPatrick K Ha, Thomas A Pilkington, William H Westra, et al.
Pageof 15